Saturday, December 15, 2018 4:57:51 PM
1. https://www.insysrx.com/products/approved
2. https://www.caratherapeutics.com/pipeline-technology/our-pipeline/
3. https://www.corbuspharma.com/pipeline/overview
4. https://zynerba.com/in-development/
I like the fact that other companies are doing trials because it tells the story of the future in Pharma and if you are first to market or have the most offerings then all that follow will be graded against your pipeline,that being said I think we are in that pole position.
The OTC line aswell as the drink and NHP line will see revenue on many fronts and show Tetra to be a diversified company and if it remains whole will be worth many billions in the future and then theres the possibility of selling off a division or two to expand the real gravy train which will be the division holding the PPP001 thru PPP005 line.
A GW type market cap is closer then you think and although we have 5 times the amount of shares as GW we will have 10 times the revenue ,then theres Tilray ,look at the action that took it to $300.00 a share ,that type of feeding frenzy could very well touch our Tetra in 2020-2021.That $300.00 was US dollars.
Lets get thru Dec and enjoy all that 2019 offers.
.. comments from that other board.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM